Clinical Trial Update: Endometriosis Patients Undergoing Quinagolide Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating quinagolide for endometriosis and hyperprolactinemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis
• Hyperprolactinemia

Drugs mentioned

• quinagolide (quinagolide)

Snippet

Sponsor: Instituto Valenciano de Infertilidad, IVI VALENCIA | Conditions: Hyperprolactinemia, Endometriosis | Phase 4 | Status: COMPLETED